Barakat RR - Search Results

1

Molecular profiling of endometrial cancers from African-American and Caucasian women.

Ferguson SE, Olshen AB, Levine DA, Viale A, Barakat RR, Boyd J. Ferguson SE, et al. Among authors: barakat rr. Gynecol Oncol. 2006 May;101(2):209-13. doi: 10.1016/j.ygyno.2005.11.028. Epub 2005 Dec 27. Gynecol Oncol. 2006. PMID: 16380157

2

Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma.

Ferguson SE, Olshen AB, Viale A, Awtrey CS, Barakat RR, Boyd J. Ferguson SE, et al. Among authors: barakat rr. Gynecol Oncol. 2004 Feb;92(2):719-25. doi: 10.1016/j.ygyno.2003.10.038. Gynecol Oncol. 2004. PMID: 14766275

3

Evaluation of germline PTEN mutations in endometrial cancer patients.

Black D, Bogomolniy F, Robson ME, Offit K, Barakat RR, Boyd J. Black D, et al. Among authors: barakat rr. Gynecol Oncol. 2005 Jan;96(1):21-4. doi: 10.1016/j.ygyno.2004.09.024. Gynecol Oncol. 2005. PMID: 15589575

4

Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles.

Ferguson SE, Olshen AB, Viale A, Barakat RR, Boyd J. Ferguson SE, et al. Among authors: barakat rr. Clin Cancer Res. 2005 Mar 15;11(6):2252-7. doi: 10.1158/1078-0432.CCR-04-1353. Clin Cancer Res. 2005. PMID: 15788674

5

Comparison of uterine malignancies that develop during and following tamoxifen therapy.

Ferguson SE, Soslow RA, Amsterdam A, Barakat RR. Ferguson SE, et al. Among authors: barakat rr. Gynecol Oncol. 2006 May;101(2):322-6. doi: 10.1016/j.ygyno.2005.10.026. Epub 2005 Dec 13. Gynecol Oncol. 2006. PMID: 16352333

6

Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma.

Black D, Soslow RA, Levine DA, Tornos C, Chen SC, Hummer AJ, Bogomolniy F, Olvera N, Barakat RR, Boyd J. Black D, et al. Among authors: barakat rr. J Clin Oncol. 2006 Apr 10;24(11):1745-53. doi: 10.1200/JCO.2005.04.1574. Epub 2006 Mar 20. J Clin Oncol. 2006. PMID: 16549821

7

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.

Diefenbach CS, Shah Z, Iasonos A, Barakat RR, Levine DA, Aghajanian C, Sabbatini P, Hensley ML, Konner J, Tew W, Spriggs D, Fleisher M, Thaler H, Dupont J. Diefenbach CS, et al. Among authors: barakat rr. Gynecol Oncol. 2007 Feb;104(2):435-42. doi: 10.1016/j.ygyno.2006.08.028. Epub 2006 Oct 4. Gynecol Oncol. 2007. PMID: 17023034

8

Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?

Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, Soslow RA, Dao F, Sonoda Y, Levine DA, Brown CL, Chi DS, Barakat RR, Gemignani ML. Abu-Rustum NR, et al. Among authors: barakat rr. Gynecol Oncol. 2009 May;113(2):163-9. doi: 10.1016/j.ygyno.2009.01.003. Epub 2009 Feb 20. Gynecol Oncol. 2009. PMID: 19232699 Free PMC article. Clinical Trial.

9

Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer.

Kehoe SM, Zivanovic O, Ferguson SE, Barakat RR, Soslow RA. Kehoe SM, et al. Among authors: barakat rr. Gynecol Oncol. 2010 May;117(2):229-33. doi: 10.1016/j.ygyno.2010.01.047. Epub 2010 Mar 2. Gynecol Oncol. 2010. PMID: 20199802

10

A microRNA survival signature (MiSS) for advanced ovarian cancer.

Shih KK, Qin LX, Tanner EJ, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat RR, Levine DA. Shih KK, et al. Among authors: barakat rr. Gynecol Oncol. 2011 Jun 1;121(3):444-50. doi: 10.1016/j.ygyno.2011.01.025. Epub 2011 Feb 26. Gynecol Oncol. 2011. PMID: 21354599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page